Profil
Andrew Nash currently works at CSL Innovation Pty Ltd., as Chief Executive Officer & Director, The Macfarlane Burnet Institute For Medical Research & Public, as Director, The Garvan Institute of Medical Research, as Director, and Denteric Pty Ltd., as Director.
Dr. Nash also formerly worked at Arovella Therapeutics Ltd., as Non-Executive Director from 2025 to 2026 and CSL Ltd., as Chief Scientific Officer, SVP & Head-Research from 2020 to 2025.
Aktive Positionen von Andrew Nash
| Unternehmen | Position | Beginn |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Vorstandsvorsitzender | - |
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services Provides medical research and public health services | Direktor/Vorstandsmitglied | - |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Direktor/Vorstandsmitglied | - |
Denteric Pty Ltd.
Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops vaccines for treating and preventing severe periodontal disease | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andrew Nash
| Unternehmen | Position | Ende |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 04.05.2026 |
| CSL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2025 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Arovella Therapeutics Ltd.
Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services Provides medical research and public health services | Commercial Services |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Commercial Services |
Denteric Pty Ltd.
Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops vaccines for treating and preventing severe periodontal disease | Commercial Services |
















